Priority Date: 07.09.11 (EP 20110382286)

STRATEGIES FOR PREVENTION AND/OR TREATMENT OF DISEASES BASED ON CD40 SILENCING

  • Application ID: EP12755881
  • Status: █ APPLICATION DEEMED TO BE WITHDRAWN

Attorney

Employment test 11 - 50 employees
Missing person image thumb Missing person image thumb Missing person image thumb
Company dna abg patentes sl
operating since 2003
1151.01
ABG Patentes SL
Headquarter in Madrid and 1 office
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). ABG Patentes SL is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB and 183 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 07.09.2011 - Priority Date (EP 20110382286)
  • 14.03.2013 - Publication A1 (WO2013034684)
  • 16.07.2014 - Publication A1 (EP2753695)

IPC Classification